Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | In |
| Molecular Weight | 114.818 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[In]
InChI
InChIKey=CXQHBGCUHODCNP-UHFFFAOYSA-N
InChI=1S/In.3H
| Molecular Formula | In |
| Molecular Weight | 114.818 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Indium sulfate (In2(SO4)3) is a grayish-white powder. It is hydroscopic and has a monoclinic crystal structure. Indium sulfate is being marketed as the newest miracle dietary supplement and is falsely advertised as a dietary aid as an enhancer of food and mineral absorption, an anti-aging supplement, a blood pressure lowering supplement. There is no scientific support for claims that indium has beneficial effects. Indium sulfate can cause the accumulation of indium in the kidney, oxidative damage, pathological changes and dysfunction in the kidney of rats.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [Renal damage of indium sulfate on rats]. | 2018-05 |
|
| The role of lysosomes in the phenomenon of concentration of aluminum and indium in the female reproductive system. An ultrastructural study. | 2017-12 |
|
| [Protection from experimental indium sulfate nephrosis (effect of ferrous dextran)]. | 1968-09 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/30082017
32 healthy Wistar rats were randomly and equally divided into 3 dose groups (52.3 mg/kg,104.6 mg/kg, 261.4 mg/kg) and one negative control group. Indium sulfate was orally given once a day successively 5 days a week for 8 weeks
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:35:52 GMT 2025
by
admin
on
Mon Mar 31 18:35:52 GMT 2025
|
| Record UNII |
045A6V3VFX
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DSLD |
1477 (Number of products:28)
Created by
admin on Mon Mar 31 18:35:52 GMT 2025 , Edited by admin on Mon Mar 31 18:35:52 GMT 2025
|
||
|
NCI_THESAURUS |
C637
Created by
admin on Mon Mar 31 18:35:52 GMT 2025 , Edited by admin on Mon Mar 31 18:35:52 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C66827
Created by
admin on Mon Mar 31 18:35:52 GMT 2025 , Edited by admin on Mon Mar 31 18:35:52 GMT 2025
|
PRIMARY | |||
|
6972
Created by
admin on Mon Mar 31 18:35:52 GMT 2025 , Edited by admin on Mon Mar 31 18:35:52 GMT 2025
|
PRIMARY | |||
|
Indium
Created by
admin on Mon Mar 31 18:35:52 GMT 2025 , Edited by admin on Mon Mar 31 18:35:52 GMT 2025
|
PRIMARY | |||
|
DB11659
Created by
admin on Mon Mar 31 18:35:52 GMT 2025 , Edited by admin on Mon Mar 31 18:35:52 GMT 2025
|
PRIMARY | |||
|
045A6V3VFX
Created by
admin on Mon Mar 31 18:35:52 GMT 2025 , Edited by admin on Mon Mar 31 18:35:52 GMT 2025
|
PRIMARY | |||
|
045A6V3VFX
Created by
admin on Mon Mar 31 18:35:52 GMT 2025 , Edited by admin on Mon Mar 31 18:35:52 GMT 2025
|
PRIMARY | |||
|
D007204
Created by
admin on Mon Mar 31 18:35:52 GMT 2025 , Edited by admin on Mon Mar 31 18:35:52 GMT 2025
|
PRIMARY | |||
|
100000128352
Created by
admin on Mon Mar 31 18:35:52 GMT 2025 , Edited by admin on Mon Mar 31 18:35:52 GMT 2025
|
PRIMARY | |||
|
231-180-0
Created by
admin on Mon Mar 31 18:35:52 GMT 2025 , Edited by admin on Mon Mar 31 18:35:52 GMT 2025
|
PRIMARY | |||
|
m6257
Created by
admin on Mon Mar 31 18:35:52 GMT 2025 , Edited by admin on Mon Mar 31 18:35:52 GMT 2025
|
PRIMARY | Merck Index | ||
|
5359967
Created by
admin on Mon Mar 31 18:35:52 GMT 2025 , Edited by admin on Mon Mar 31 18:35:52 GMT 2025
|
PRIMARY | |||
|
30430
Created by
admin on Mon Mar 31 18:35:52 GMT 2025 , Edited by admin on Mon Mar 31 18:35:52 GMT 2025
|
PRIMARY | |||
|
DTXSID8052485
Created by
admin on Mon Mar 31 18:35:52 GMT 2025 , Edited by admin on Mon Mar 31 18:35:52 GMT 2025
|
PRIMARY | |||
|
1362699
Created by
admin on Mon Mar 31 18:35:52 GMT 2025 , Edited by admin on Mon Mar 31 18:35:52 GMT 2025
|
PRIMARY | RxNorm | ||
|
SUB35310
Created by
admin on Mon Mar 31 18:35:52 GMT 2025 , Edited by admin on Mon Mar 31 18:35:52 GMT 2025
|
PRIMARY | |||
|
7440-74-6
Created by
admin on Mon Mar 31 18:35:52 GMT 2025 , Edited by admin on Mon Mar 31 18:35:52 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |